Studying the Efficacy of Aspirin & Clopidogrel in Healthy Subjects With Stable Coronary Artery Disease.

Summary

The investigators will test the hypothesis that aspirin or clopidogrel taken twice daily will augment their antiplatelet efficacy in patients with an elevated platelet turnover (as measured by the proportion of reticulated (young) platelets) compared with once daily dosing.

Timeline

Start

2009-09

Primary completion

2011-08

Completion

2011-09

Outcome

Outcome not reported

Stopped (Business): “No funding secured.”

Drugs

Indications